AVENCORE advised a pharma company preparing to acquire a third party research laboratory. Given the combined unit’s ambitions, establishing a robust business oriented foundation capable of addressing new market segments and integrating partners was necessary.
To bring all parties involved to a shared consensus, we assisted the company’s top management in producing a business plan that capitalized on all parties’ abilities and know-how. The resulting organization outlined the roles, contributions and responsibilities of all stakeholders, in reaching the company’s new goals.
The final shareholders’ agreement addressed all parties’ requirements and set a target to double revenue within six years and expand into 15 new countries.
